Tevogen Bio Holdings Inc (TVGN) - News Archive

The field of oncology has witnessed remarkable advancements in recent years, particularly in the realm of immunotherapy. Among these breakthroughs, harnessing the power of cytotoxic T lymphocytes (CTLs) has emerged as a...

Tevogen Bio, a leading biotech company, has recently announced its successful issuance of Series A-1 Preferred Stock at a conversion price of $10. This exciting news is expected to significantly impact the company s sha...